Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: Results from three prospective randomized trials

Cancer Journal

Volumn 12, Issue 2, 2006, Pages 123-129

  Rewari, Amar N ^a   Haffty, Bruce G ^a,b   Wilson, Lynn D ^a   Son, Yung H ^a   Joe, John K ^a   Ross, Douglas A ^a   Papac, Rose J ^a   Sasaki, Clarence T ^a   Fischer, James J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Chemotherapy; Mitomycin; Postoperative radiotherapy; Randomized trial; Squamous cell carcinoma of the head and neck

Indexed keywords

DICOUMAROL; MITOMYCIN; MITOMYCIN C; PORFIROMYCIN;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA AND VOMITING; OROPHARYNX CANCER; OROPHARYNX TUMOR; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RISK ASSESSMENT; RISK FACTOR; SKIN INFLAMMATION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 33645890552     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Laramore GE, Scott CB, al-Sarraf M et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 1992;23:705-713.
2. Hong WK. Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 1992;23:885-886.
3. Kramer S, Gelber RD, Snow JB et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987;10:19-30.
4. Bernier J, Domenge C, Ozsahin M et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-1952.
5. Cooper JS, Pajak TF, Forastiere AA et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-1944.
6. Haffty BG, Wilson LD, Son YH et al. Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial. Int J Radiat Oncol Biol Phys 2005;61:119-128.
7. Haffty BG, Son YH, Papac R et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. J Clin Oncol 1997;15:268-276.
8. Weissberg JB, Son YH, Papac RJ et al. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 1989;17:3-9.
9. Haffty BG, Son YH, Sasaki CT et al. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Int J Radiat Oncol Biol Phys 1993;27:241-250.
10. Smid L, Budihna M, Zakotnik B et al. Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 2003;56:1055-1062.
11. Bachaud JM, Cohen-Jonathan E, Alzieu C et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996;36:999-1004.
12. Greene FL, Page DL, Fleming ID et al, eds. AJCC Cancer Staging Manual. New York: Springer-Verlag; 2002.
13. Kaplan EL, Meier PL. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
15. Huang DT, Johnson CR, Schmidt-Ullrich R et al. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study. Int J Radiat Oncol Biol Phys 1992;23:737-742.
16. Lundahl RE, Foote RL, Bonner JA et al. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis. Int J Radiat Oncol Biol Phys 1998;40:529-534.
17. Sartorelli AC. Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res 1988;48:775-778.
18. Sartorelli AC, Hodnick WF, Belcourt MF et al. Mitomycin C: a prototype bioreductive agent. Oncol Res 1994;6:501-508.
19. Rockwell S, Hughes CS. Effects of mitomycin C and porfiromycin on exponentially growing and plateau phase cultures. Cell Prolif 1994;27:153-163.